Reporting Payment Clause Samples
The REPORTING; PAYMENT clause establishes the obligations of one party to provide regular reports and make payments to the other party as specified in the agreement. Typically, this clause outlines the frequency and format of required reports, such as sales figures or usage data, and sets deadlines and methods for payment of amounts due, like royalties or service fees. Its core function is to ensure transparency and timely financial transactions between the parties, reducing the risk of disputes over information or payment delays.
Reporting Payment. Morphic will provide ▇▇▇▇▇▇▇ with a report of the estimated amounts due under Section 2.3.1 (Allocation of Costs) in the current Calendar Quarter no later than [***] prior to the end of such Calendar Quarter. Within [***] after the end of each Calendar Quarter, unless such timing is adjusted by the Parties in writing, Morphic will provide ▇▇▇▇▇▇▇ with an invoice of actual FTE Costs and Out-of-Pocket Costs incurred in connection with the performance of the Morphic Research Activities during the prior Calendar Quarter for which ▇▇▇▇▇▇▇ is obligated to reimburse Morphic pursuant to Section 2.3.1 (Allocation of Costs), each of which invoices will contain a detailed and itemized calculation (consistent with ▇▇▇▇▇▇▇’▇ then current internal reporting format previously provided to Morphic) of such costs incurred. ▇▇▇▇▇▇▇ will pay all amounts (other than those amounts that ▇▇▇▇▇▇▇ disputes in good faith in accordance with the terms and conditions of this Agreement) set forth in each such invoice in accordance with Section 8.11 (Invoicing and Payment).
Reporting Payment. An employee who reports for work at their regularly scheduled time and is advised for the first time that there is no work available, shall be given at the Employer’s option four (4) hours’ work or four (4) hours’ pay at their applicable hourly rate. For employees regularly scheduled to work less than four (4) hours the obligation is reduced to the number of hours regularly scheduled to work. This obligation is not applicable where the employee has failed to keep the Employer aware of their telephone number.
Reporting Payment. During the Term, within 30 days after the end of each calendar quarter, Trac Medical shall furnish to Homecare Association a statement based upon the amounts due pursuant to Sections 6.2 for the quarter then ended (a "Statement"). The Statement will detail the total Net Revenues collected by Trac Medical and will identify the royalty share percentage and the associated royalty dollar amount payable to Homecare Association. Homecare Association will have ten (10) business days after its receipt of the Statement to dispute any part of the Statement. Within fifteen (15) business days after receipt of the Statement by Homecare Association, Trac Medical will pay to Homecare Association the royalty dollar amounts indicated on the Statement and that are not disputed by Homecare Association. In the event Homecare Association and Trac Medical dispute the Statement, Trac Medical shall pay the undisputed amount in accordance with the previous sentence and the disputed amounts shall be paid within five (5) business days after the dispute is resolved. [ * Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.]
Reporting Payment. Continuous Reporting Module Periodic Reporting Module - Final Reporting
Reporting Payment. An employee who reports to work as scheduled or is called into work on assigned day off and reports as requested by the Employer and no work is available, shall receive a minimum of three (3) hours pay at not apply in the event of an emergency which disrupts the normal operations of the nursing home or whenever an employee has received prior notice not to report to work,nor shall it apply to employees returning to work without notice after absence. (This Article applies to both full-time and part-time employees)
Reporting Payment. (a) Within three (3) weeks of the end of each calendar quarter, Licensee must submit a report by email to providing the following information for such calendar quarter (the “Report”):
(i) the total quantity of Licensed Products sold on an SKU-by-SKU and country-by-country basis (with descriptions so that each individual Licensed Product can be identified by SKU within each country);
(ii) the total Net Sales value of Licensed Products on an SKU-by-SKU and country-by-country basis;
(iii) the amount of Royalties payable to Licensor from the foregoing information (for clarity, identifying Refrigerant Royalties and 1234yf Royalties separately) and, if applicable, any associated deductions or withholding contemplated by Section 3.8;
(iv) a list of all customers who purchased Licensed Products from Licensee; and
(v) the NPS.
(b) Following receipt of each Report, Licensor will issue an invoice (each, a “Royalty Invoice”) to Licensee (within approximately two (2) weeks) stating the amount of Royalties owed by Licensee to Licensor based on Net Sales for the applicable calendar quarter. Licensee shall pay to Licensor the amount stated in each Royalty Invoice within two (2) weeks of the date such Royalty Invoice is sent by Licensor to Licensee. All payments of Royalties shall be made in U.S. Dollars and by wire transfer to: JPMorgan Chase Bank Honeywell International Inc. ABA ▇▇▇▇▇▇▇▇▇ Swift Code: ▇▇▇▇▇▇▇▇ Account Number: 662635853 HIPI Agreement Number: 2025-XXXX
Reporting Payment a. Text omitted per Request for Confidential Treatment by Pinnacle Business Management, Inc.
b. Text omitted per Request for Confidential Treatment by Pinnacle Business Management, Inc.
c. Text omitted per Request for Confidential Treatment by Pinnacle Business Management, Inc.
Reporting Payment. No later than [**] following the end of each Calendar Quarter during the Research Program Period during which Moderna incurs any Preclinical Research Program Costs or Clinical Development Research Program Costs, Moderna shall deliver to Immatics a written report setting forth, in reasonable detail with supporting documentation in a format mutually agreed by the Parties, the Preclinical Research Program Costs and Clinical Development Research Program Costs incurred by Moderna during such Calendar Quarter. No later than [**] following Immatics’ receipt of Moderna’s report, Immatics shall calculate the total amount of Preclinical Research Program Costs or Clinical Development Research Program Costs incurred by the Parties during such Calendar Quarter and provide Moderna written notice, in reasonable detail with supporting documentation in a format mutually agreed by the Parties, of the amount of reimbursement of Preclinical Research Program Costs or Clinical Development Research Program Costs to which Immatics or Moderna is entitled in accordance with Section 9.1.1. If Immatics is entitled to Preclinical Research Program Costs or Clinical Development Research Program Costs, Immatics shall invoice Moderna for such amount, and Moderna shall pay such amount within [**] after receipt of such invoice. If Moderna is entitled to Preclinical Research Program Costs or Clinical Development Research Program Costs, Moderna shall invoice Immatics for such amount, and Immatics shall pay such amount within [**] after receipt of such invoice. Without limiting the foregoing in this Section 9.1.2, each Party shall cooperate with any reasonable request of the other Party to confirm the information in any such report(s) and invoice(s) in accordance with Section 9.2.
Reporting Payment. Athenex shall provide Almirall with the Day 57 ▇▇▇▇▇ ▇/▇▇▇▇▇ ▇ Contact Sensitization Data, 12 Months Phase 3 Long-Term Recurrence Data and Line Extension [*] Phase II Data promptly following each of their respectively availability to Athenex. Almirall shall have forty five (45) days to evaluate if Data obtained from any such study is satisfactory. Athenex will be entitled to issue the corresponding invoice that will be paid by Almirall and/or Aqua under this Section 4.2 in accordance with Section 4.7(a) below.
Reporting Payment. An employee who reports to work as scheduled or is called into work on his/her assigned day off and reports as requested by the Employer and no work is available, shall receive a minimum of three (3) hours pay at his/her regular straight time hourly rate. The Employer may elect to assign the employee to any other work in the nursing home which the Employer determines the employee is able to perform. This reporting allowance shall not apply in the event of an emergency which disrupts the normal operations of the nursing home or whenever an employee has received prior notice not to report to work, nor shall it apply to employees returning to work without notice after absence.